Tyrosine Phosphorylation of p85 Relieves Its Inhibitory Activity on Phosphatidylinositol 3-Kinase

Bruce D. Cuevas, Yiling Lu, Muling Mao, Jinyi Zhang, Ruth LaPushin, Kathy Siminovitch, Gordon Mills

Research output: Contribution to journalArticle

188 Citations (Scopus)

Abstract

Under resting conditions, the p85 regulatory subunit of phosphatidylinositol 3-kinase (PI3K) serves to both stabilize and inactivate the p110 catalytic subunit. The inhibitory activity of p85 is relieved by occupancy of the NH2-terminal SH2 domain of p85 by phosphorylated tyrosine. Src family kinases phosphorylate tyrosine 688 in p85, a process that we have shown to be reversed by the activity of the p85-associated SH2 domain-containing phosphatase SHP1. We demonstrate that phosphorylation of the downstream PI3K target Akt is increased in cells lacking SHP1, implicating phosphorylation of p85 in the regulation of PI3K activity. Furthermore, the in vitro specific activity of PI3K associated with tyrosine-phosphorylated p85 is higher than that associated with nonphosphorylated p85. Expression of wild-type p85 inhibits PI3K enzyme activity as indicated by PI3K-dependent Akt phosphorylation. The inhibitory activity of p85 is accentuated by mutation of tyrosine 688 to alanine and reversed by mutation of tyrosine 688 to aspartic acid, changes that block and mimic tyrosine phosphorylation, respectively Strikingly, mutation of tyrosine 688 to aspartic acid completely reverses the inhibitory activity of p85 on cell viability and activation of the downstream targets Akt and NFκB, indicative of the physiological relevance of p85 phosphorylation. Tyrosine phosphorylation of Tyr688 or mutation of tyrosine 688 to aspartic acid is sufficient to allow binding to the NH 2-terminal SH2 domain of p85. Thus an intramolecular interaction between phosphorylated Tyr688 and the NH2-terminal SH2 domain of p85 can relieve the inhibitory activity of p85 on p110. Taken together, the data indicate that phosphorylation of Tyr688 in p85 leads to a novel mechanism of PI3K regulation.

Original languageEnglish (US)
Pages (from-to)27455-27461
Number of pages7
JournalJournal of Biological Chemistry
Volume276
Issue number29
DOIs
StatePublished - Jul 20 2001
Externally publishedYes

Fingerprint

Phosphatidylinositol 3-Kinase
Phosphorylation
Tyrosine
src Homology Domains
Aspartic Acid
Mutation
Non-Receptor Type 6 Protein Tyrosine Phosphatase
src-Family Kinases
Enzyme activity
Alanine
Catalytic Domain
Cell Survival
Chemical activation
Cells

ASJC Scopus subject areas

  • Biochemistry

Cite this

Tyrosine Phosphorylation of p85 Relieves Its Inhibitory Activity on Phosphatidylinositol 3-Kinase. / Cuevas, Bruce D.; Lu, Yiling; Mao, Muling; Zhang, Jinyi; LaPushin, Ruth; Siminovitch, Kathy; Mills, Gordon.

In: Journal of Biological Chemistry, Vol. 276, No. 29, 20.07.2001, p. 27455-27461.

Research output: Contribution to journalArticle

Cuevas, Bruce D. ; Lu, Yiling ; Mao, Muling ; Zhang, Jinyi ; LaPushin, Ruth ; Siminovitch, Kathy ; Mills, Gordon. / Tyrosine Phosphorylation of p85 Relieves Its Inhibitory Activity on Phosphatidylinositol 3-Kinase. In: Journal of Biological Chemistry. 2001 ; Vol. 276, No. 29. pp. 27455-27461.
@article{39b3b142bc3a46d089bb09d65cba6594,
title = "Tyrosine Phosphorylation of p85 Relieves Its Inhibitory Activity on Phosphatidylinositol 3-Kinase",
abstract = "Under resting conditions, the p85 regulatory subunit of phosphatidylinositol 3-kinase (PI3K) serves to both stabilize and inactivate the p110 catalytic subunit. The inhibitory activity of p85 is relieved by occupancy of the NH2-terminal SH2 domain of p85 by phosphorylated tyrosine. Src family kinases phosphorylate tyrosine 688 in p85, a process that we have shown to be reversed by the activity of the p85-associated SH2 domain-containing phosphatase SHP1. We demonstrate that phosphorylation of the downstream PI3K target Akt is increased in cells lacking SHP1, implicating phosphorylation of p85 in the regulation of PI3K activity. Furthermore, the in vitro specific activity of PI3K associated with tyrosine-phosphorylated p85 is higher than that associated with nonphosphorylated p85. Expression of wild-type p85 inhibits PI3K enzyme activity as indicated by PI3K-dependent Akt phosphorylation. The inhibitory activity of p85 is accentuated by mutation of tyrosine 688 to alanine and reversed by mutation of tyrosine 688 to aspartic acid, changes that block and mimic tyrosine phosphorylation, respectively Strikingly, mutation of tyrosine 688 to aspartic acid completely reverses the inhibitory activity of p85 on cell viability and activation of the downstream targets Akt and NFκB, indicative of the physiological relevance of p85 phosphorylation. Tyrosine phosphorylation of Tyr688 or mutation of tyrosine 688 to aspartic acid is sufficient to allow binding to the NH 2-terminal SH2 domain of p85. Thus an intramolecular interaction between phosphorylated Tyr688 and the NH2-terminal SH2 domain of p85 can relieve the inhibitory activity of p85 on p110. Taken together, the data indicate that phosphorylation of Tyr688 in p85 leads to a novel mechanism of PI3K regulation.",
author = "Cuevas, {Bruce D.} and Yiling Lu and Muling Mao and Jinyi Zhang and Ruth LaPushin and Kathy Siminovitch and Gordon Mills",
year = "2001",
month = "7",
day = "20",
doi = "10.1074/jbc.M100556200",
language = "English (US)",
volume = "276",
pages = "27455--27461",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "29",

}

TY - JOUR

T1 - Tyrosine Phosphorylation of p85 Relieves Its Inhibitory Activity on Phosphatidylinositol 3-Kinase

AU - Cuevas, Bruce D.

AU - Lu, Yiling

AU - Mao, Muling

AU - Zhang, Jinyi

AU - LaPushin, Ruth

AU - Siminovitch, Kathy

AU - Mills, Gordon

PY - 2001/7/20

Y1 - 2001/7/20

N2 - Under resting conditions, the p85 regulatory subunit of phosphatidylinositol 3-kinase (PI3K) serves to both stabilize and inactivate the p110 catalytic subunit. The inhibitory activity of p85 is relieved by occupancy of the NH2-terminal SH2 domain of p85 by phosphorylated tyrosine. Src family kinases phosphorylate tyrosine 688 in p85, a process that we have shown to be reversed by the activity of the p85-associated SH2 domain-containing phosphatase SHP1. We demonstrate that phosphorylation of the downstream PI3K target Akt is increased in cells lacking SHP1, implicating phosphorylation of p85 in the regulation of PI3K activity. Furthermore, the in vitro specific activity of PI3K associated with tyrosine-phosphorylated p85 is higher than that associated with nonphosphorylated p85. Expression of wild-type p85 inhibits PI3K enzyme activity as indicated by PI3K-dependent Akt phosphorylation. The inhibitory activity of p85 is accentuated by mutation of tyrosine 688 to alanine and reversed by mutation of tyrosine 688 to aspartic acid, changes that block and mimic tyrosine phosphorylation, respectively Strikingly, mutation of tyrosine 688 to aspartic acid completely reverses the inhibitory activity of p85 on cell viability and activation of the downstream targets Akt and NFκB, indicative of the physiological relevance of p85 phosphorylation. Tyrosine phosphorylation of Tyr688 or mutation of tyrosine 688 to aspartic acid is sufficient to allow binding to the NH 2-terminal SH2 domain of p85. Thus an intramolecular interaction between phosphorylated Tyr688 and the NH2-terminal SH2 domain of p85 can relieve the inhibitory activity of p85 on p110. Taken together, the data indicate that phosphorylation of Tyr688 in p85 leads to a novel mechanism of PI3K regulation.

AB - Under resting conditions, the p85 regulatory subunit of phosphatidylinositol 3-kinase (PI3K) serves to both stabilize and inactivate the p110 catalytic subunit. The inhibitory activity of p85 is relieved by occupancy of the NH2-terminal SH2 domain of p85 by phosphorylated tyrosine. Src family kinases phosphorylate tyrosine 688 in p85, a process that we have shown to be reversed by the activity of the p85-associated SH2 domain-containing phosphatase SHP1. We demonstrate that phosphorylation of the downstream PI3K target Akt is increased in cells lacking SHP1, implicating phosphorylation of p85 in the regulation of PI3K activity. Furthermore, the in vitro specific activity of PI3K associated with tyrosine-phosphorylated p85 is higher than that associated with nonphosphorylated p85. Expression of wild-type p85 inhibits PI3K enzyme activity as indicated by PI3K-dependent Akt phosphorylation. The inhibitory activity of p85 is accentuated by mutation of tyrosine 688 to alanine and reversed by mutation of tyrosine 688 to aspartic acid, changes that block and mimic tyrosine phosphorylation, respectively Strikingly, mutation of tyrosine 688 to aspartic acid completely reverses the inhibitory activity of p85 on cell viability and activation of the downstream targets Akt and NFκB, indicative of the physiological relevance of p85 phosphorylation. Tyrosine phosphorylation of Tyr688 or mutation of tyrosine 688 to aspartic acid is sufficient to allow binding to the NH 2-terminal SH2 domain of p85. Thus an intramolecular interaction between phosphorylated Tyr688 and the NH2-terminal SH2 domain of p85 can relieve the inhibitory activity of p85 on p110. Taken together, the data indicate that phosphorylation of Tyr688 in p85 leads to a novel mechanism of PI3K regulation.

UR - http://www.scopus.com/inward/record.url?scp=0035920129&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035920129&partnerID=8YFLogxK

U2 - 10.1074/jbc.M100556200

DO - 10.1074/jbc.M100556200

M3 - Article

C2 - 11337495

AN - SCOPUS:0035920129

VL - 276

SP - 27455

EP - 27461

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 29

ER -